Duration of gonadotropin-releasing hormone antagonist administration does not affect the outcome of subsequent frozen-thawed cycles

Fertility and Sterility

Volumn 81, Issue 2, 2004, Pages 473-475

  Zikopoulos, Kostantinos ^a   Kolibianakis, Efstratios M ^a   Camus, Michael ^a   Tournaye, Herman ^a   Van Den Abbeel, Etienne ^a   Joris, Hubert ^a   Van Steirteghem, André ^a   Devroey, Paul ^a  

^a CENTRE FOR REPRODUCTIVE MEDICINE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CLOMIFENE CITRATE; GANIRELIX; GONADORELIN ANTAGONIST; HUMAN MENOPAUSAL GONADOTROPIN; RECOMBINANT FOLLITROPIN;

ARTICLE; CRYOPRESERVATION; EMBRYO; EMBRYO TRANSFER; FEMALE; FEMALE INFERTILITY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; OVARY; PREGNANCY; PRIORITY JOURNAL; STIMULATION; THAWING;

EID: 1242329009     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2003.08.009     Document Type: Article

References (14)

1. Al-Inany H., Aboulghar M. GnRH antagonist in assisted reproduction a Cochrane review . Hum Reprod. 17:2002;874-885.
2. Hernandez E.R. Embryo implantation and GnRH antagonists the Rubicon for GnRH antagonists . Hum Reprod. 15:2000;1211-1216.
3. Mannaerts B., Gordon K. Embryo implantation and GnRH antagonists GnRH antagonists do not activate the GnRH receptor . Hum Reprod. 9:2000;1882-1883.
4. Diedrich K., Frydman R., Devroey P., Felberbaum R., Schally A.V., Engel J. Comment on the debate article Embryo implantation the Rubicon for GnRH antagonists . Hum Reprod. 6:2001;1305-1306.
5. Ortmann O., Weiss J.M., Diedrich K. Embryo implantation and GnRH antagonists ovarian actions on GnRH antagonists . Hum Reprod. 4:2001;608-611.
6. Kolibianakis E, Devroey P. Effect of GnRH-antagonists on implantation: a critical appraisal. Ferti Net October. 2002 www.ferti.net.
7. Kolibianakis E., Bourgain C., Albano C., Osmanagaoglu K., Smitz J., Van Steirteghem A., et al. Effect of ovarian stimulation with recombinant follicle-stimulating hormone, gonadotropin-releasing hormone antagonists, and human chorionic gonadotropin on endometrial maturation on the day of oocyte pick-up. Fertil Steril. 5:2002;1025-1029.
8. Kaufman R., Menezo Y., Hazout A., Nicollet B., Dumont M., Servy E. Cocultured blastocysts cryopreservation experience of more than 500 transfer cycles . Fertil Steril. 64:1995;1125-1129.
9. Kolibianakis E., Tournaye H., Osmanagaoglou K., Camus M., Van Waesberghe L., Van Steirteghem A., et al. Outcome for donors and recipients in two egg-sharing policies. Fertil Steril. 79:2003;69-73.
10. Wang J.X., Yap Y.Y., Payne D., Jeffrey R., Mathews C.D. Frozen-thawed embryo transfer influence of clinical factors on implantation rate and risk of multiple conception . Hum Reprod. 16:2001;2316-2319.
11. Kol S., Lightman A., Hilljensjo T., Devroey P., Fauser B., Tarlatzis B., et al. High doses of gonadotropin releasing hormone antagonist in in-vitro fertilization cycles do not adversely affect the outcome of subsequent freeze-thaw cycles. Hum Reprod. 14:1999;2242-2244.
12. Seeling A.S., Al-Hasani S., Katalinic A., Schopper B., Sturm R., Diedrich K., et al. Comparison of cryopreservation outcome with gonadotropin-releasing hormone agonists or antagonists in the collecting cycle. Fertil Steril. 3:2002;472-475.
13. Langley MT, Marek DM, Gardner DK, Doody KM, Doody KJ. Extended embryo culture in human assisted reproduction treatments. Hum Reprod 2002;16:902-8.
14. Behr B., Gebhardt J., Lyon J., Miki A.A. Factors relating to a successful cryopreserved blastocyst transfer program. Fertil Steril. 77:2002;697-699.